What's breaking now, across thousands of outlets.
(RTTNews) - Tuesday, Eli Lilly (LLY) said Foundayo 17.2 mg showed greater weight loss and A1C reductions than oral semaglutide 25 mg in an indirect treatment comparison involving adults with type 2 diabetes.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
From selecting the right system to overcoming integration challenges, discover how automated liquid handling can support flexible, reproducible laboratory workflows.
Teen sadness and suicidal thoughts have declined below pandemic-era peaks, offering real optimism without minimizing those who are still struggling.
Dr. Jay Bhattacharya sought to spread a deadly pathogen. Does he belong in the HHS Hall of Heroes with legends who tried to contain them?
Dénia turned its coastline into a sea of solidarity as breast cancer survivors and rowing teams came together for a […]
